Lisata Therapeutics Inc. logo

Lisata Therapeutics Inc.

LSTA | NASDAQ
Chart Builder DCF Calculator
$1.58
+$0.02 (+1.28%)
Sep 22, 2026, 11:31 AM ET · Market open

Market Data

Market Cap
$14.21M
Enterprise Value
$3.76M
Beta
0.80
Average Volume
205.15K
Shares Outstanding (Diluted)
9.11M
Shares Change YoY
5.82%
Institutional Ownership
11.74%
Exchange
NASDAQ
ISIN
US1280583022

Price Performance

Price Change 1M
-4.3%
Price Change 3M
-55.0%
Price Change 6M
-68.9%
Price Change YTD
-20.4%
Price Change 1Y
-31.9%
Price Change 3Y
-24.6%
Price Change 5Y
-91.5%
1M CAGR (ann.)
47.2%
1Y CAGR (ann.)
-34.7%
5Y CAGR (ann.)
-39.1%
All-Time CAGR
-37.0%

Valuation

PE Ratio
-0.95
Forward PE
N/A
PEG Ratio
-0.03
Forward PEG
-0.15
PS Ratio
142.06
Forward PS
2.80
PB Ratio
1.72
P/FCF Ratio
-0.92
P/Adj. FCF Ratio
-0.85
P/OCF Ratio
-1.16
EV/Sales
37.63
EV/EBIT
-0.31
EV/EBITDA
-0.31
EV/FCF
-0.24
Earnings Yield
-105.1%
FCF Yield
-108.5%
Adj. FCF Yield
-118.3%

Financial Health

Net Cash
$10.44M
Total Debt
$0
Cash & Short-Term Investments
$10.44M
Total Assets
$11.03M
Current Ratio
3.69
Quick Ratio
3.69
Debt / Equity Ratio
0.00
Debt / EBITDA
-0.00
Debt / FCF
-0.00
OCF / Debt
N/A
Interest Coverage
0.00
Altman Z-Score
-72.56
Piotroski F-Score
1

Margins & Profitability

Gross Profit Margin
95.0%
Operating Profit Margin
-12435.0%
EBITDA Margin
-16007.0%
Net Profit Margin
-14621.0%
FCF Margin
-15406.0%
Adj. FCF Margin
-16805.0%
SBC / Revenue
1035.0%
SBC Impact (per share)
-9.1%

Returns

Return on Assets
-132.6%
Return on Equity
-113.8%
Return on Invested Capital
-199.1%
Return on Capital Employed
-204.3%
Return on Tangible Assets
-132.6%

Historical Growth (CAGR)

Revenue CAGR 3Y
12.8%
Revenue CAGR 5Y
54.3%
Revenue CAGR 10Y
-43.3%
EPS CAGR 3Y
21.7%
EPS CAGR 5Y
37.2%
EPS CAGR 10Y
7.8%
FCF CAGR 3Y
13.2%
FCF CAGR 5Y
8.9%
FCF CAGR 10Y
1.6%

Analyst Forecasts

Analyst Rating
Hold
Analyst Count
2
EPS Growth Next 3Y
N/A
Revenue Growth Next 3Y
666.3%
Earnings Date
Nov 4, 2026
EPS Estimate (next Q)
-$1.12
EPS Growth Est (next Q)
129.6%
Revenue Est (next Q)
$659K
Revenue Growth Est (next Q)
N/A

Cash Flow

Operating Cash Flow
$-15.41M
Free Cash Flow
$-15.41M
Adj. Free Cash Flow
$-16.81M
FCF Per Share
-$1.35
OCF Per Share
-$1.35
OCF/S Ratio
-12323.0%

Income Statement

Revenue
$100K
Gross Profit
$98K
Operating Income
$-12.44M
EBITDA
$-12.02M
Net Income
$-14.62M
EPS (Diluted)
-$1.64
Revenue / Employee
$4.76K
Profit / Employee
$-696.24K
Employees
21

© 2026 bestshares.com. All rights reserved.